American Healthcare REIT (MEX:AHR) Research & Development: MXN0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AHR American Healthcare REIT Inc MEX:AHR
45 GF Score
Price MXN897.00
GF Value MXN531.75
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is American Healthcare REIT Research & Development?

American Healthcare REIT MEX:AHR 45 Research & Development is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:AHR with a GF Score™ of 45/100 and a GF Value™ of MXN531.75 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. American Healthcare REIT's Research & Development for the three months ended in Jun. 2026 was MXN0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was MXN0 Mil.

American Healthcare REIT  (MEX:AHR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

American Healthcare REIT Research & Development Related Terms

American Healthcare REIT Research & Development Historical Data

* Premium members only.

The historical data trend for American Healthcare REIT's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Healthcare REIT Research & Development Chart

American Healthcare REIT Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

American Healthcare REIT Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:AHR
45GF Score
American Healthcare REIT Inc MEX:AHR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Healthcare REIT Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN0 Mil mean?
American Healthcare REIT (MEX:AHR) has a Research & Development of MXN0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on American Healthcare REIT and its competitors.
Is American Healthcare REIT's Research & Development too high?
American Healthcare REIT's current Research & Development is MXN0 Mil. Overall, American Healthcare REIT has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Healthcare REIT's Research & Development compare to CTRE and HR?
American Healthcare REIT's Research & Development of MXN0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on American Healthcare REIT and its competitors. American Healthcare REIT's current Research & Development is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, American Healthcare REIT (MEX:AHR) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN531.75, compared to a current price of MXN897.00 — trading 68.7% above its estimated fair value. The current Research & Development is MXN0 Mil. American Healthcare REIT's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For American Healthcare REIT (MEX:AHR), the current Research & Development is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is American Healthcare REIT (MEX:AHR) Overvalued in 2026?

Based on GuruFocus' analysis, American Healthcare REIT stock appears to be overvalued. The current stock price of MXN897.00 is trading 68.7% above its estimated GF Value™ of MXN531.75. GuruFocus considers American Healthcare REIT to be Significantly Overvalued.

Key valuation signals for MEX:AHR:

  • Research & Development: MXN0 Mil
  • GF Value™: MXN531.75 vs. price of MXN897.00 (68.7% above fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the MEX:AHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

American Healthcare REIT Business Description

Industry Real EstateREITs
Other Exchanges AHR:USA
Address 18191 Von Karman Avenue, Suite 300, Irvine, CA, USA, 92612
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
45GF Score

Get the complete analysis for MEX:AHR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN897.00
Price
MXN531.75
GF Value